Total Payments
$8,976
2024 Payments
$436.66
Companies
21
Transactions
61
Medicare Patients
5,192
Medicare Billing
$530,222
Payment Breakdown by Category
Research$7,733 (86.1%)
Food & Beverage$1,168 (13.0%)
Education$75.00 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,733 | 3 | 86.1% |
| Food and Beverage | $1,168 | 55 | 13.0% |
| Education | $75.00 | 3 | 0.8% |
Payments by Type
Research
$7,733
3 transactions
General
$1,243
58 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $7,733 | 3 | $0 (2020) |
| Medtronic, Inc. | $283.50 | 16 | $0 (2024) |
| Novo Nordisk Inc | $168.91 | 5 | $0 (2024) |
| Abbott Laboratories | $103.42 | 5 | $0 (2024) |
| Ascensia Diabetes Care US Inc. | $90.68 | 1 | $0 (2017) |
| Amgen Inc. | $76.42 | 3 | $0 (2024) |
| Currax Pharmaceuticals LLC | $75.00 | 3 | $0 (2023) |
| ABBVIE INC. | $69.86 | 4 | $0 (2022) |
| Tandem Diabetes Care, Inc. | $58.67 | 4 | $0 (2023) |
| Nevro Corp. | $52.41 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $436.66 | 18 | Medtronic, Inc. ($210.16) |
| 2023 | $271.82 | 14 | Currax Pharmaceuticals LLC ($75.00) |
| 2022 | $75.60 | 4 | ABBVIE INC. ($21.05) |
| 2021 | $120.24 | 6 | Nevro Corp. ($52.41) |
| 2020 | $7,733 | 3 | Eli Lilly and Company ($7,733) |
| 2019 | $17.84 | 1 | Acella Pharmaceuticals, LLC ($17.84) |
| 2018 | $136.18 | 7 | Senseonics, Incorporated ($43.00) |
| 2017 | $184.80 | 8 | Ascensia Diabetes Care US Inc. ($90.68) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Durable Pump | ||||||
| 12/18/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Durable Pump | ||||||
| 11/22/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.67 | General |
| 11/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: Durable Pump | ||||||
| 09/11/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: Durable Pump | ||||||
| 09/11/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $0.16 | General |
| Category: Durable Pump | ||||||
| 09/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: Durable Pump | ||||||
| 06/22/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $45.52 | General |
| 06/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Diabetes | ||||||
| 06/22/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: Durable Pump | ||||||
| 06/20/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $166.60 | General |
| Category: Durable Pump | ||||||
| 06/11/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: Durable Pump | ||||||
| 05/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes Care | ||||||
| 05/17/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Durable Pump | ||||||
| 05/17/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: Durable Pump | ||||||
| 04/26/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: Durable Pump | ||||||
| 01/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $88.33 | General |
| 11/30/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 11/15/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 10/30/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Endocrinology | ||||||
| 10/27/2023 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Automated insulin delivery system | ||||||
| 10/18/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 10/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2, PARALLEL, COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN INSULIN NAIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $3,938 | 2 |
| A PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY3209590 IN STUDY PARTICIPANTS WITH TYPE 1 DIABETES MELLITUS PREVIOUSLY TREATED WITH MULTIPLE DAILY INJECTION THERAPY | Eli Lilly and Company | $3,795 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,209 | 20,973 | $355,132 | $118,982 |
| 2022 | 8 | 1,345 | 24,067 | $417,623 | $144,816 |
| 2021 | 8 | 1,343 | 24,254 | $419,779 | $147,879 |
| 2020 | 10 | 1,295 | 22,329 | $393,217 | $118,546 |
Total Patients
5,192
Total Services
91,623
Medicare Billing
$530,222
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 729 | 932 | $223,680 | $81,193 | 36.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 209 | 215 | $62,995 | $16,940 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $22,200 | $6,450 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 40 | $12,880 | $5,088 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 64 | $10,112 | $3,977 | 39.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 81 | 131 | $13,100 | $3,377 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 146 | $8,614 | $1,552 | 18.0% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 11 | 19,385 | $1,551 | $405.03 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 861 | 1,197 | $287,280 | $106,454 | 37.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 222 | 231 | $67,683 | $19,628 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $19,610 | $5,954 | 30.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 99 | 163 | $16,300 | $4,316 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 59 | $9,322 | $3,777 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 16 | $5,152 | $2,266 | 44.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 178 | $10,502 | $1,964 | 18.7% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2022 | 11 | 22,170 | $1,774 | $457.61 | 25.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 810 | 1,181 | $283,440 | $105,396 | 37.2% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 221 | 230 | $67,390 | $20,366 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 124 | 131 | $20,698 | $7,924 | 38.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $18,500 | $6,166 | 33.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 84 | 124 | $12,400 | $3,290 | 26.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 17 | $5,474 | $2,385 | 43.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 25 | 171 | $10,089 | $1,867 | 18.5% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2021 | 13 | 22,350 | $1,788 | $484.47 | 27.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 712 | 1,050 | $252,000 | $77,754 | 30.9% |
About Dr. Luis Casaubon, M.D
Dr. Luis Casaubon, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447225495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Casaubon, M.D has received a total of $8,976 in payments from pharmaceutical and medical device companies, with $436.66 received in 2024. These payments were reported across 61 transactions from 21 companies. The most common payment nature is "" ($7,733).
As a Medicare-enrolled provider, Casaubon has provided services to 5,192 Medicare beneficiaries, totaling 91,623 services with total Medicare billing of $530,222. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Austin, TX
- Active Since 02/22/2006
- Last Updated 01/06/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1447225495
Products in Payments
- MINIMED 780G (Device) $248.86
- CONTOUR NEXT ONE Meter (Device) $90.68
- NEXLETOL (Drug) $75.00
- FREESTYLE LIBRE 3 (Device) $47.02
- Ozempic (Drug) $46.07
- NP Thyroid (Drug) $43.48
- Eversense (Device) $43.00
- t-slim insulin pump (Device) $40.25
- Rybelsus (Drug) $34.51
- Omnia (Device) $33.71
- Omnipod (Device) $26.84
- JARDIANCE (Drug) $26.03
- Synthroid (Drug) $24.70
- Androgel (Drug) $24.11
- InPen (Device) $23.15
- SYNTHROID (Drug) $21.05
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $20.67
- FREESTYLE LIBRE (Device) $20.57
- Senza (Device) $18.70
- TEPEZZA (Biological) $18.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Austin
Dr. Thomas Blevins, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Endocrinology, Diabetes & Metabolism $1.5M
Michele Mcdermott, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $137,974
Endocrinology, Diabetes & Metabolism $137,974
Tira Chaicha-Brom, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $56,872
Endocrinology, Diabetes & Metabolism $56,872
Dr. Simona Scumpia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $52,573
Endocrinology, Diabetes & Metabolism $52,573
Dr. Padma Horvit, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $20,822
Endocrinology, Diabetes & Metabolism $20,822
Farheen Yousuf, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,161
Endocrinology, Diabetes & Metabolism $9,161